MYC and Miyoshi myopathy: 3.2. High-Risk MM Patients Identified with the RNA-Seq-Based Risk Score Are Characterized by Enrichment of Genes Related to Cell Proliferation, Growth Factor Signaling, MYC Pathway and Epigenetic Deregulation